Wildner O - Search Results

1

Expansion of hepatic and hematopoietic stem cells utilizing mouse embryonic liver explants.

Monga SP, Tang Y, Candotti F, Rashid A, Wildner O, Mishra B, Iqbal S, Mishra L. Monga SP, et al. Among authors: wildner o. Cell Transplant. 2001 Jan-Feb;10(1):81-9. Cell Transplant. 2001. PMID: 11294475

2

Expansion of Hepatic and Hematopoietic Stem Cells Utilizing Mouse Embryonic Liver Explants.

Monga SPS, Tang Y, Candotti F, Rashid A, Wildner O, Mishra B, Iqbal S, Mishra L. Monga SPS, et al. Among authors: wildner o. Cell Transplant. 2001 Jan;10(1):81-89. doi: 10.3727/000000001783986945. Cell Transplant. 2001. PMID: 28880670 Free article.

3

Enzyme prodrug gene therapy: synergistic use of the herpes simplex virus-cellular thymidine kinase/ganciclovir system and thymidylate synthase inhibitors for the treatment of colon cancer.

Wildner O, Blaese RM, Candotti F. Wildner O, et al. Cancer Res. 1999 Oct 15;59(20):5233-8. Cancer Res. 1999. PMID: 10537302

4

Generation of a conditionally neo(r)-containing retroviral producer cell line: effects of neo(r) on retroviral titer and transgene expression.

Wildner O, Candotti F, Krecko EG, Xanthopoulos KG, Ramsey WJ, Blaese RM. Wildner O, et al. Gene Ther. 1998 May;5(5):684-91. doi: 10.1038/sj.gt.3300654. Gene Ther. 1998. PMID: 9797874

5

The role of the E1B 55 kDa gene product in oncolytic adenoviral vectors expressing herpes simplex virus-tk: assessment of antitumor efficacy and toxicity.

Wildner O, Morris JC. Wildner O, et al. Cancer Res. 2000 Aug 1;60(15):4167-74. Cancer Res. 2000. PMID: 10945625

6

Adenoviral vectors capable of replication improve the efficacy of HSVtk/GCV suicide gene therapy of cancer.

Wildner O, Morris JC, Vahanian NN, Ford H Jr, Ramsey WJ, Blaese RM. Wildner O, et al. Gene Ther. 1999 Jan;6(1):57-62. doi: 10.1038/sj.gt.3300810. Gene Ther. 1999. PMID: 10341876

7

Synergy between the herpes simplex virus tk/ganciclovir prodrug suicide system and the topoisomerase I inhibitor topotecan.

Wildner O, Blaese RM, Morris JC. Wildner O, et al. Hum Gene Ther. 1999 Nov 1;10(16):2679-87. doi: 10.1089/10430349950016726. Hum Gene Ther. 1999. PMID: 10566896

8

AV.TK-mediated killing of subcutaneous tumors in situ results in effective immunization against established secondary intracranial tumor deposits.

Okada T, Shah M, Higginbotham JN, Li Q, Wildner O, Walbridge S, Oldfield E, Blaese RM, Ramsey WJ. Okada T, et al. Among authors: wildner o. Gene Ther. 2001 Sep;8(17):1315-22. doi: 10.1038/sj.gt.3301526. Gene Ther. 2001. PMID: 11571568

9

In situ generation of pseudotyped retroviral progeny by adenovirus-mediated transduction of tumor cells enhances the killing effect of HSV-tk suicide gene therapy in vitro and in vivo.

Okada T, Caplen NJ, Ramsey WJ, Onodera M, Shimazaki K, Nomoto T, Ajalli R, Wildner O, Morris J, Kume A, Hamada H, Blaese RM, Ozawa K. Okada T, et al. Among authors: wildner o. J Gene Med. 2004 Mar;6(3):288-99. doi: 10.1002/jgm.490. J Gene Med. 2004. PMID: 15026990

10

Efficient directional cloning of recombinant adenovirus vectors using DNA-protein complex.

Okada T, Ramsey WJ, Munir J, Wildner O, Blaese RM. Okada T, et al. Among authors: wildner o. Nucleic Acids Res. 1998 Apr 15;26(8):1947-50. doi: 10.1093/nar/26.8.1947. Nucleic Acids Res. 1998. PMID: 9518487 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

60 results

Search Page

Filters